Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrogenolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN109678855A offers high-yield Avibactam intermediate synthesis. Reduces cost and improves supply chain reliability for pharmaceutical manufacturers.
Patent CN102516233B details a cost-effective Reformatsky route for voriconazole, eliminating palladium catalysts and simplifying purification for reliable supply chains.
Novel route for Cabazitaxel (XRP6258) using DMSO/Acetic Anhydride. High yield, scalable process for pharmaceutical intermediates reducing production costs.
Patent CN111978320B reveals a high-yield two-step route for renin inhibitor intermediates, offering significant cost reduction in API manufacturing and scalable production.
Novel preparation method for Tezacaftor via reductive cyclization. High purity, low cost, scalable industrial process for API intermediates.
Patent CN112979498A reveals a high-yield synthesis route for 3-fluoro-4-trifluoromethyl benzonitrile, offering cost reduction in API manufacturing and improved supply chain reliability.
Novel patent CN115611860B details a safer high-yield nilaparib synthesis route eliminating sodium azide and chiral resolution for cost-effective manufacturing and supply chain stability.
Patent CN112679498A reveals a high-purity route for beta-lactamase inhibitors, offering significant cost and supply chain advantages for API manufacturers.
Patent CN111533745A details a scalable 3-step synthesis for triazolodiazepine intermediates. Discover cost-effective manufacturing routes and supply chain advantages for pharmaceutical applications.
Patent CN102093292A reveals a safe two-step route for DL-alpha-aminocaprolactam, eliminating toxic azides for reliable pharmaceutical intermediates manufacturing.
Patent CN115611860A discloses a safe, high-yield Niraparib synthesis avoiding sodium azide. Ideal for cost reduction in API manufacturing and supply chain stability.
Eliminate NaN3 hazards in DL-α-aminocaprolactam production. This two-step method offers high yields (81-85%) and simplified purification, reducing supply chain risks for lysine manufacturing.